TD Cowen analyst Gary Taylor lowered the firm’s price target on HCA Healthcare (HCA) to $440 from $450 and keeps a Buy rating on the shares. The firm updated its model following 3Q24 results. Investors had lofty expectations coming into 3Q but underlying performance was solid with SS revenues up 7.1% against a 3Q23 7.9% comp.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $406 from $427 at Morgan Stanley
- HCA Healthcare price target lowered to $420 from $475 at KeyBanc
- Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
- Morning Movers: Capri sinks after judge blocks planned takeover by Tapestry
- HCA Healthcare Reports Strong Q3 2024 Results